SciBase: Capital raise explained
Scibase Holding
Nicklas Andersson – Mannen som andas och lever aktier
Note Q1´24: Greentech och Kina backar - De långsiktiga tillväxt och- lönsamhetsmålen består
Note
Uppesittarkväll 24/4 från Inderes Event Studio
Mendus: Changing the course of cancer treatment
Mendus
Diamyd Medical: Stora steg tagna mot autoimmun diabetes
Diamyd Medical
PUUILO: a top-performing DYI discount chain
Puuilo
Keeping cancer in check
Mendus
Initiation of coverage Mendus: Keeping cancer in check
Mendus
Gross margin improved faster than expected
H&M
Orthex erövrar Europa med förvaringsboxar och hög ESG profil
Orthex
Scanfil Q4 & CMD: Inside sells not worrying
Scanfil
Metacon: Är grön vätgas framtiden?
Metacon
HAKI Safety Kapitalmarknadsdag: Välrustade framåt
HAKI Safety
NOTE Q4´23: Kortsiktigt missnöjd - Långsiktigt tillitsfull
Note
Mendus Business Update: CEO Erik Manting is sleeping well
Mendus
MGI Q4´23: Återhämtning på reklammarknaden
MGI - Media and Games Invest
INCAP Q4’23: The botten is nådd
Incap
NIBE Q4´23: Räcker det att nå förväntningarna?
Nibe Industrier
Hexicon Q4´23: Varit en utmanande period - Positiva framåt
Hexicon
RevolutionRace Q2: Fortsätter ta marknadsandelar
RVRC Holding
A reasonably significant new contract for Aiforia in the veterinary sector
Purmo Q1 morning result: Expectations beat, on par with last year
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Scanfil Q4 morning result: Fundamentals appear to be intact despite operational underperformance
Innofactor: Steady good work in a challenging market
Growth continues by capturing domestic market share
Outlook not significantly brightened
Inderes Group - Marching pace to accelerate - SEB
Lindex Q1 on Friday: Performance forecasted to be similar as last year
Hexagon Q1 report on Monday: We expect moderate growth and improving gross margins
SP Group (One-pager): Guidance suggests a return to growth in 2024
Enento Q1'24: Guidance must wait
Expres2ion Biotechnologies: Receives dividends from AdaptVac
Popularity of stocks today means poor returns tomorrow
Inderes Group . Q1: In-line report - SEB
Looks like the house is in a disarray
Remedy Q1 on Monday: Our forecast sees AW2 royalties only starting to show in the figures in H2
Tecnotree Q1 on Friday: Growth slowing down
SciBase: Capital raise explained
OrderYOYO - Recording of Q1 2024 result presentation
Upcoming webcasts
Latest research
Innofactor: Steady good work in a challenging market
Accumulate
Innofactor
2024-04-24
Growth continues by capturing domestic market share
Accumulate
Puuilo
2024-04-24
Outlook not significantly brightened
Accumulate
Enento Group
2024-04-24
Inderes Group - Marching pace to accelerate - SEB
Inderes
2024-04-23
SP Group (One-pager): Guidance suggests a return to growth in 2024
SP Group
2024-04-23